Nexalin Technology (NXL) Change in Account Payables (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Change in Account Payables of -$76480.0 for Q1 2026, down 400.57% year-over-year from $25445.0 in Q1 2025, and down 142.49% quarter-over-quarter from $179996.0 in Q4 2025.
Nexalin Technology (NXL) Change in Account Payables (2021 - 2026) Analysis & Trends
Nexalin Technology's Change in Account Payables history runs 6 years deep, the most recent figure standing at -$76480.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 400.57% year-over-year to -$76480.0; the TTM figure through Mar 2026 stood at -$13296.0 (down 144.49% YoY), while the FY2025 annual figure was $88629.0, up 2572.22% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$76480.0, down from $179996.0 in the prior quarter.
- The five-year high for Change in Account Payables was $179996.0 in Q4 2025, with the low at -$353609.0 in Q1 2023.
- The 5-year median for Change in Account Payables is $3743.0 (2023), against an average of -$16257.4.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables tumbled 1819.8% in 2024, then jumped 1799.2% in 2025.
- Nexalin Technology's Change in Account Payables stood at -$139926.0 in 2022, then jumped by 162.17% to $86985.0 in 2023, then sank by 112.18% to -$10593.0 in 2024, then surged by 1799.2% to $179996.0 in 2025, then tumbled by 142.49% to -$76480.0 in 2026.
- Business Quant data shows NXL's Change in Account Payables at -$76480.0 in Q1 2026, $179996.0 in Q4 2025, and -$168228.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | 71,349.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71,349.00 |
| Jun 30, 2026 | 71,349.00 |
| Mar 31, 2026 | -76,480.00 |
| Mar 31, 2026 | -76,480.00 |
| Dec 31, 2025 | 179,996.00 |
| Dec 31, 2025 | 179,996.00 |
| Sep 30, 2025 | -168,228.00 |
| Sep 30, 2025 | -168,228.00 |
| Jun 30, 2025 | 51,416.00 |
| Jun 30, 2025 | 51,416.00 |
| Mar 31, 2025 | 25,445.00 |
| Mar 31, 2025 | 25,445.00 |
| Dec 31, 2024 | -10,593.00 |
| Dec 31, 2024 | -10,593.00 |
| Sep 30, 2024 | 79,404.00 |
| Sep 30, 2024 | 79,404.00 |
| Jun 30, 2024 | -64,372.00 |
| Jun 30, 2024 | -64,372.00 |
| Mar 31, 2024 | -8,024.00 |
| Mar 31, 2024 | -8,024.00 |